Greater Ciprofloxacin Tolerance as a Possible Selectable Phenotype Underlying the Pandemic Spread of the H30 Subclone of Escherichia coli Sequence Type 131.

Authors

James R Johnson
Stephen B Porter
Paul Thuras
Timothy J Johnson
Lance B. Price, George Washington UniversityFollow
Veronika Tchesnokova
Evgeni V Sokurenko

Document Type

Journal Article

Publication Date

11-1-2015

Journal

Antimicrobial Agents and Chemotherapy

Volume

59

Issue

11

Inclusive Pages

7132-5

DOI

10.1128/AAC.01687-15

Keywords

Anti-Bacterial Agents--pharmacology; Ciprofloxacin/pharmacology; Escherichia coli--drug effects

Comments

This is an open access PubMed Central article. Click on link for full-text access.

APA Citation

Johnson, J. R., Porter, S. B., Thuras, P., Johnson, T. J., Price, L. B., Tchesnokova, V., & Sokurenko, E. V. (2015). Greater ciprofloxacin tolerance as a possible selectable phenotype underlying the pandemic spread of the H30 subclone of escherichia coli sequence type 131. Antimicrobial Agents and Chemotherapy, 59(11), 7132-7135. doi:10.1128/AAC.01687-15

Peer Reviewed

1

Open Access

1